BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 1898713)

  • 1. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
    Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of nitrofurothiazole bladder carcinogens.
    Spry L; Lakshmi VM; Zenser T; Davis B
    J Pharmacol Exp Ther; 1986 Aug; 238(2):457-62. PubMed ID: 3735127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
    Swaminathan S; Bryan GT
    Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver NADPH-dependent oxidation of the 5-nitrofurans, FANFT and ANFT, by guinea pig and rat.
    Dawley RM; Lakshmi VM; Babu SR; Zenser TV; Davis BB
    Xenobiotica; 1993 Feb; 23(2):193-203. PubMed ID: 8498082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
    Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB
    J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioconversion and macromolecular binding of 2-amino-4-(5-nitro-2-furyl)thiazole by cultured rat urothelial cells.
    Swaminathan S; Johnson MD; Reznikoff CA; Bryan GT
    Cancer Res; 1984 Dec; 44(12 Pt 1):5511-6. PubMed ID: 6498813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
    Spry LA; Zenser TV; Cohen SM; Davis BB
    J Clin Invest; 1985 Sep; 76(3):1025-31. PubMed ID: 4044826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole.
    Hayashida S; Wang CY
    Mutat Res; 1984 Mar; 135(3):169-73. PubMed ID: 6369128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of aromatic and heterocyclic amine bladder carcinogens: bioanalytical considerations.
    Mattammal MB; Lakshmi VM; Zenser TV; Davis BB
    J Pharm Biomed Anal; 1990; 8(2):151-8. PubMed ID: 2128813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal metabolic/excretory coupling.
    Spry LA; Rubinstein J; Rettke C; Zenser TV; Davis BB
    Am J Physiol; 1988 Jan; 254(1 Pt 2):F145-52. PubMed ID: 3337242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens.
    Matsushima M; Bryan GT
    Cancer Res; 1980 Jun; 40(6):1897-901. PubMed ID: 7371022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
    Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
    Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole.
    Wise RW; Zenser TV; Davis BB
    Cancer Res; 1983 Apr; 43(4):1518-22. PubMed ID: 6403225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermospray high performance liquid chromatography/mass spectrometric identification of a bladder carcinogen metabolite isolated from guinea pig urine.
    Mattammal MB; Lakshmi VM; Dawley RM; Zenser TV; Davis BB; Hsu FF
    Biomed Environ Mass Spectrom; 1990 Oct; 19(10):601-8. PubMed ID: 2285827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding.
    Mattammal MB; Zenser TV; Davis BB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4961-6. PubMed ID: 6796263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase.
    Zenser TV; Palmier MO; Mattammal MB; Davis BB
    Carcinogenesis; 1984 Oct; 5(10):1225-30. PubMed ID: 6435896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylbutazone peroxidatic metabolism and conjugation.
    Lakshmi VM; Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):81-8. PubMed ID: 8331577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl)thiazole.
    Mann AM; Masui T; Chlapowski FJ; Okamura T; Borgeson CD; Cohen SM
    Carcinogenesis; 1991 Mar; 12(3):417-22. PubMed ID: 2009588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats.
    Morton KC; Wang CY
    Cancer Res; 1983 Aug; 43(8):3628-32. PubMed ID: 6190554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.